Patent Linkage Mechanisms: Legal Shields or Market Barriers?

Authors

  • Srikumaran Paramasivam JSS College of Pharmacy, Ooty, Udhagamandalam - 643 001, India
  • Murugappan Mahalingam JSS College of Pharmacy, Ooty, Udhagamandalam - 643 001, India
  • Sabarinath Iyyappan JSS College of Pharmacy, Ooty, Udhagamandalam - 643 001, India
  • Dharanidharan Ganesan JSS College of Pharmacy, Ooty, Udhagamandalam - 643 001, India

DOI:

https://doi.org/10.56042/jipr.v31i6.23396

Keywords:

Patent Linkage, TRIPS-plus, Generic Drug Access, Hatch-Waxman Act, Evergreening, Drug Price Inflation, Intellectual Property Law, KORUS FTA, Pharmaceutical Regulation

Abstract

Patent linkage system—the act of linking the marketing approval to the status of the patent of the innovator—has emerged as a powerful yet difficult mechanism of the intersection of intellectual property, public health, and intellectual property. This review analyses the legal foundations, international violations, and health consequences related to patent linkage across different countries like the US, Canada, South Korea, Australia, India, China, and Brazil. While the innovators argue that it incentivizes the innovations, the collected evidence states that the patent linkage system delays generic entry, increases drug prices, and includes regulatory burdens on agencies that make patent claim assessments harder. This article further examines how TRIPS-Plus obligations linked with bilateral and plurilateral trade agreements have exported these mechanisms to countries with limited capacity to balance innovations with access. Starting from cross-national legal analysis, economic modelling, and policy outcomes, this review explains institutional asymmetries, gaps in empirical evidence, and judicial dilemmas. It concludes the forward-looking recommendations focused on regulatory redesign, independent patent validation, and health-centred policy safeguards to better align innovation incentives with equal access to medicines.

Downloads

Published

2026-11-20

How to Cite

Patent Linkage Mechanisms: Legal Shields or Market Barriers?. (2026). Journal of Intellectual Property Rights (JIPR), 31(6), 1017-1027. https://doi.org/10.56042/jipr.v31i6.23396

Similar Articles

41-50 of 320

You may also start an advanced similarity search for this article.